ICU MEDICAL INC/DE - ICUI
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | — | J | D | 704.0 | 0.0 | 0.0 | 4,046.0 | View | |
| Mar 16, 2026 | Chairman and CEO | M | D | 17,100.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 16, 2026 | Chairman and CEO | M | D | 4,872.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 16, 2026 | Chairman and CEO | F | D | 2,693.0 | 125.85 | 338,914.05 | 126,833.0 | View | |
| Mar 16, 2026 | Chairman and CEO | M | A | 4,872.0 | 0.0 | 0.0 | 129,526.0 | View | |
| Mar 16, 2026 | Chairman and CEO | F | D | 9,452.0 | 125.85 | 1,189,534.2 | 124,654.0 | View | |
| Mar 16, 2026 | Chairman and CEO | M | A | 17,100.0 | 0.0 | 0.0 | 134,106.0 | View | |
| Mar 16, 2026 | VP, General Counsel | M | D | 5,700.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 16, 2026 | VP, General Counsel | M | D | 1,624.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 16, 2026 | VP, General Counsel | F | D | 897.0 | 125.85 | 112,887.45 | 21,907.0 | View | |
| Mar 16, 2026 | VP, General Counsel | M | A | 1,624.0 | 0.0 | 0.0 | 22,804.0 | View | |
| Mar 16, 2026 | VP, General Counsel | F | D | 3,150.0 | 125.85 | 396,427.5 | 21,180.0 | View | |
| Mar 16, 2026 | VP, General Counsel | M | A | 5,700.0 | 0.0 | 0.0 | 24,330.0 | View | |
| Mar 16, 2026 | Chief Information Officer | M | D | 1,300.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 16, 2026 | Chief Information Officer | F | D | 718.0 | 125.85 | 90,360.3 | 5,326.0 | View | |
| Mar 16, 2026 | Chief Information Officer | M | A | 1,300.0 | 0.0 | 0.0 | 6,044.0 | View | |
| Mar 16, 2026 | VP, GM-Infusion Capital | M | D | 2,924.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 16, 2026 | VP, GM-Infusion Capital | F | D | 1,295.0 | 125.85 | 162,975.75 | 24,602.0 | View | |
| Mar 16, 2026 | VP, GM-Infusion Capital | M | A | 2,924.0 | 0.0 | 0.0 | 25,897.0 | View | |
| Mar 16, 2026 | Chief Operating Officer | M | D | 11,400.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 16, 2026 | Chief Operating Officer | M | D | 3,248.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 16, 2026 | Chief Operating Officer | F | D | 1,795.0 | 125.85 | 225,900.75 | 46,306.0 | View | |
| Mar 16, 2026 | Chief Operating Officer | M | A | 3,248.0 | 0.0 | 0.0 | 48,101.0 | View | |
| Mar 16, 2026 | Chief Operating Officer | F | D | 6,301.0 | 125.85 | 792,980.85 | 44,853.0 | View | |
| Mar 16, 2026 | Chief Operating Officer | M | A | 11,400.0 | 0.0 | 0.0 | 51,154.0 | View | |
| Mar 16, 2026 | Chief Financial Officer | M | D | 11,400.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 16, 2026 | Chief Financial Officer | M | D | 3,248.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 16, 2026 | Chief Financial Officer | F | D | 1,795.0 | 125.85 | 225,900.75 | 71,750.0 | View | |
| Mar 16, 2026 | Chief Financial Officer | M | A | 3,248.0 | 0.0 | 0.0 | 73,545.0 | View | |
| Mar 16, 2026 | Chief Financial Officer | F | D | 5,800.0 | 125.85 | 729,930.0 | 70,297.0 | View | |
| Mar 16, 2026 | Chief Financial Officer | M | A | 11,400.0 | 0.0 | 0.0 | 76,097.0 | View | |
| Mar 09, 2026 | Chief Financial Officer | M | D | 71,757.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 09, 2026 | Chief Financial Officer | M | D | 3,522.0 | 0.0 | 0.0 | 7,044.0 | View | |
| Mar 09, 2026 | Chief Financial Officer | F | D | 39,667.0 | 132.0 | 5,236,044.0 | 64,697.0 | View | |
| Mar 09, 2026 | Chief Financial Officer | M | A | 71,757.0 | 0.0 | 0.0 | 104,364.0 | View | |
| Mar 09, 2026 | Chief Financial Officer | F | D | 1,263.0 | 0.0 | 0.0 | 32,607.0 | View | |
| Mar 09, 2026 | Chief Financial Officer | M | A | 3,522.0 | 0.0 | 0.0 | 33,870.0 | View | |
| Mar 09, 2026 | Chairman and CEO | M | D | 107,635.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 09, 2026 | Chairman and CEO | M | D | 5,282.0 | 0.0 | 0.0 | 10,566.0 | View | |
| Mar 09, 2026 | Chairman and CEO | F | D | 59,500.0 | 132.0 | 7,854,000.0 | 117,006.0 | View | |
| Mar 09, 2026 | Chairman and CEO | M | A | 107,635.0 | 0.0 | 0.0 | 176,506.0 | View | |
| Mar 09, 2026 | Chairman and CEO | F | D | 2,919.0 | 0.0 | 0.0 | 68,871.0 | View | |
| Mar 09, 2026 | Chairman and CEO | M | A | 5,282.0 | 0.0 | 0.0 | 71,790.0 | View | |
| Mar 09, 2026 | Chief Operating Officer | M | D | 71,757.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 09, 2026 | Chief Operating Officer | M | D | 3,522.0 | 0.0 | 0.0 | 7,044.0 | View | |
| Mar 09, 2026 | Chief Operating Officer | F | D | 39,667.0 | 132.0 | 5,236,044.0 | 39,754.0 | View | |
| Mar 09, 2026 | Chief Operating Officer | M | A | 71,757.0 | 0.0 | 0.0 | 79,421.0 | View | |
| Mar 09, 2026 | Chief Operating Officer | F | D | 1,946.0 | 132.0 | 256,872.0 | 7,664.0 | View | |
| Mar 09, 2026 | Chief Operating Officer | M | A | 3,522.0 | 0.0 | 0.0 | 9,610.0 | View | |
| Mar 09, 2026 | VP, GM-Infusion Capital | M | D | 1,585.0 | 0.0 | 0.0 | 3,170.0 | View | |
| Mar 09, 2026 | VP, GM-Infusion Capital | M | D | 16,147.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 09, 2026 | VP, GM-Infusion Capital | M | D | 2,153.0 | 0.0 | 0.0 | 6,908.0 | View | |
| Mar 09, 2026 | VP, GM-Infusion Capital | F | D | 630.0 | 132.0 | 83,160.0 | 22,973.0 | View | |
| Mar 09, 2026 | VP, GM-Infusion Capital | M | A | 2,153.0 | 0.0 | 0.0 | 23,603.0 | View | |
| Mar 09, 2026 | VP, GM-Infusion Capital | F | D | 6,877.0 | 132.0 | 907,764.0 | 21,450.0 | View | |
| Mar 09, 2026 | VP, GM-Infusion Capital | M | A | 16,147.0 | 0.0 | 0.0 | 28,327.0 | View | |
| Mar 09, 2026 | VP, GM-Infusion Capital | F | D | 702.0 | 132.0 | 92,664.0 | 12,180.0 | View | |
| Mar 09, 2026 | VP, GM-Infusion Capital | M | A | 1,585.0 | 0.0 | 0.0 | 12,882.0 | View | |
| Mar 09, 2026 | VP, General Counsel | M | D | 23,917.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 09, 2026 | VP, General Counsel | M | D | 3,189.0 | 0.0 | 0.0 | 7,886.0 | View | |
| Mar 09, 2026 | VP, General Counsel | M | D | 2,348.0 | 0.0 | 0.0 | 11,075.0 | View | |
| Mar 09, 2026 | VP, General Counsel | F | D | 1,762.0 | 132.0 | 232,584.0 | 18,630.0 | View | |
| Mar 09, 2026 | VP, General Counsel | M | A | 3,189.0 | 0.0 | 0.0 | 20,392.0 | View | |
| Mar 09, 2026 | VP, General Counsel | F | D | 13,221.0 | 132.0 | 1,745,172.0 | 17,203.0 | View | |
| Mar 09, 2026 | VP, General Counsel | M | A | 23,917.0 | 0.0 | 0.0 | 30,424.0 | View | |
| Mar 09, 2026 | VP, General Counsel | F | D | 1,297.0 | 132.0 | 171,204.0 | 6,507.0 | View | |
| Mar 09, 2026 | VP, General Counsel | M | A | 2,348.0 | 0.0 | 0.0 | 7,804.0 | View | |
| Mar 09, 2026 | Chief Information Officer | M | D | 7,177.0 | 0.0 | 0.0 | 0.0 | View | |
| Mar 09, 2026 | Chief Information Officer | M | D | 957.0 | 0.0 | 0.0 | 3,775.0 | View | |
| Mar 09, 2026 | Chief Information Officer | M | D | 1,409.0 | 0.0 | 0.0 | 4,732.0 | View | |
| Mar 09, 2026 | Chief Information Officer | F | D | 529.0 | 132.0 | 69,828.0 | 4,744.0 | View | |
| Mar 09, 2026 | Chief Information Officer | M | A | 957.0 | 0.0 | 0.0 | 5,273.0 | View | |
| Mar 09, 2026 | Chief Information Officer | F | D | 3,967.0 | 132.0 | 523,644.0 | 4,316.0 | View | |
| Mar 09, 2026 | Chief Information Officer | M | A | 7,177.0 | 0.0 | 0.0 | 8,283.0 | View | |
| Mar 09, 2026 | Chief Information Officer | F | D | 782.0 | 132.0 | 103,224.0 | 1,106.0 | View | |
| Mar 09, 2026 | Chief Information Officer | M | A | 1,409.0 | 0.0 | 0.0 | 1,888.0 | View | |
| Nov 25, 2025 | VP, GM-Infusion Capital | S | D | 2,897.0 | 152.3522 | 441,364.32 | 11,297.0 | View | |
| Nov 12, 2025 | — | M | D | 1,285.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 12, 2025 | — | S | D | 1,285.0 | 140.42 | 180,439.7 | 3,995.0 | View | |
| Nov 12, 2025 | — | M | A | 1,285.0 | 103.76 | 133,331.6 | 5,280.0 | View | |
| Nov 12, 2025 | VP, General Counsel | S | D | 930.0 | 142.345 | 132,380.85 | 5,456.0 | View |